Terms: = Sarcomas AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Treatment
23 results:
1. Tumor-suppressive microRNA-152 inhibits the proliferation of Ewing's sarcoma cells by targeting CDK5R1.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Kubota Y; Tsumura H
Sci Rep; 2023 Oct; 13(1):18546. PubMed ID: 37899376
[TBL] [Abstract] [Full Text] [Related]
2. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
[TBL] [Abstract] [Full Text] [Related]
3. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Targeted Next-Generation Panel Sequencing Reveals
Marinoff AE; Spurr LF; Fong C; Li YY; Forrest SJ; Ward A; Doan D; Corson L; Mauguen A; Pinto N; Maese L; Colace S; Macy ME; Kim A; Sabnis AJ; Applebaum MA; Laetsch TW; Glade-Bender J; Weiser DA; Anderson M; Crompton BD; Meyers P; Zehir A; MacConaill L; Lindeman N; Nowak JA; Ladanyi M; Church AJ; Cherniack AD; Shukla N; Janeway KA
JCO Precis Oncol; 2023 Mar; 7():e2200334. PubMed ID: 36996377
[TBL] [Abstract] [Full Text] [Related]
5. Rethinking on the management strategy of malignant phyllodes tumor of the breast: An analysis based on the SEER database.
Chen C; Huang X; Xu Y; Sun Q
Medicine (Baltimore); 2023 Mar; 102(12):e33326. PubMed ID: 36961178
[TBL] [Abstract] [Full Text] [Related]
6. KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/ccne1 axis.
Chen B; Chen H; Lu S; Zhu X; Que Y; Zhang Y; Huang J; Zhang L; Zhang Y; Sun F; Wang J; Zhu J; Zhen Z; Zhang Y
Cell Death Dis; 2022 Apr; 13(4):354. PubMed ID: 35428764
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges.
Hsu JY; Seligson ND; Hays JL; Miles WO; Chen JL
JCO Precis Oncol; 2022 Feb; 6():e2100211. PubMed ID: 35108033
[TBL] [Abstract] [Full Text] [Related]
8. Surgical resection of primary tumor in the extremities improves survival for metastatic soft-tissue sarcoma patients: a population-based study of the SEER database.
Matsuoka M; Onodera T; Yokota I; Iwasaki K; Matsubara S; Hishimura R; Kondo E; Iwasaki N
Clin Transl Oncol; 2021 Dec; 23(12):2474-2481. PubMed ID: 34060011
[TBL] [Abstract] [Full Text] [Related]
9. Cross-cultural adaption, translation and validation of the Toronto extremity salvage score (TESS) for patients in German-speaking countries.
Trost C; Hofer C; Stamm T; Windhager R; Hobusch GM
Wien Klin Wochenschr; 2021 Jun; 133(11-12):536-542. PubMed ID: 33905027
[TBL] [Abstract] [Full Text] [Related]
10. Utility of 18F-FDG-PET/CT in management and prognostication of treatment naïve late-stage soft tissue sarcomas.
Singh TP; Sharma A; Sharma A; Bakhshi S; Patel C; Pandey AK; Dhamija E; Batra A; Kumar R
Nucl Med Commun; 2021 Jul; 42(7):818-825. PubMed ID: 33741856
[TBL] [Abstract] [Full Text] [Related]
11. Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience.
Bergeron C; Jenney M; De Corti F; Gallego S; Merks H; Glosli H; Ferrari A; Ranchère-Vince D; De Salvo GL; Zanetti I; Chisholm J; Minard-Colin V; Rogers T; Bisogno G;
Eur J Cancer; 2021 Mar; 146():21-29. PubMed ID: 33567392
[TBL] [Abstract] [Full Text] [Related]
12. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.
Okimoto RA; Wu W; Nanjo S; Olivas V; Lin YK; Ponce RK; Oyama R; Kondo T; Bivona TG
J Clin Invest; 2019 Jul; 129(8):3401-3406. PubMed ID: 31329165
[TBL] [Abstract] [Full Text] [Related]
13. GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway.
Kleinsimon S; Longmuss E; Rolff J; Jäger S; Eggert A; Delebinski C; Seifert G
Sci Rep; 2018 Apr; 8(1):5750. PubMed ID: 29636527
[TBL] [Abstract] [Full Text] [Related]
14. Postoperative Day 1 Glucose May Be Associated With Wound Complications in sarcomas Treated With Preoperative Radiation.
Bedi M; King DM; Mendez C; Slawski B; Charlson JA; Hackbarth DA; Neilson JC
Clin Orthop Relat Res; 2018 Mar; 476(3):580-586. PubMed ID: 29529645
[TBL] [Abstract] [Full Text] [Related]
15. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.
Cuppens T; Moisse M; Depreeuw J; Annibali D; Colas E; Gil-Moreno A; Huvila J; Carpén O; Zikán M; Matias-Guiu X; Moerman P; Croce S; Lambrechts D; Amant F
Int J Cancer; 2018 Mar; 142(6):1230-1243. PubMed ID: 29063609
[TBL] [Abstract] [Full Text] [Related]
16. Clinical impact of extensive molecular profiling in advanced cancer patients.
Cousin S; Grellety T; Toulmonde M; Auzanneau C; Khalifa E; Laizet Y; Tran K; Le Moulec S; Floquet A; Garbay D; Robert J; Hostein I; Soubeyran I; Italiano A
J Hematol Oncol; 2017 Feb; 10(1):45. PubMed ID: 28179005
[TBL] [Abstract] [Full Text] [Related]
17. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
[TBL] [Abstract] [Full Text] [Related]
18. Older age impacts radiotherapy-related outcomes in soft tissue sarcoma.
Yuen NK; Li CS; Monjazeb AM; Borys D; Bold RJ; Canter RJ
J Surg Res; 2015 Dec; 199(2):494-504. PubMed ID: 26163324
[TBL] [Abstract] [Full Text] [Related]
19. Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.
Lin KH; Torng PL; Tsai KH; Shih HJ; Chen CL
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):172-7. PubMed ID: 25951723
[TBL] [Abstract] [Full Text] [Related]
20. Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer.
Colombo PE; Fabbro M; Theillet C; Bibeau F; Rouanet P; Ray-Coquard I
Crit Rev Oncol Hematol; 2014 Feb; 89(2):207-16. PubMed ID: 24071502
[TBL] [Abstract] [Full Text] [Related]
[Next]
